Ad is loading...
MENU

AFMD Affimed NV Forecast, Technical & Fundamental Analysis

a developer of antibody-based therapeutic drugs

Industry Biotechnology
AFMD
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
AFMD
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

AFMD is expected to report earnings to fall 26.47% to -69 cents per share on March 27

Affimed NV AFMD Stock Earnings Reports
Q4'24
Est.
$-0.69
Q3'24
Missed
by $0.09
Q2'24
Missed
by $0.04
Q1'24
Beat
by $0.28
Q4'23
Beat
by $0.22
The last earnings report on November 14 showed earnings per share of -93 cents, missing the estimate of -85 cents. With 132.61K shares outstanding, the current market capitalization sits at 54.57M.
A.I. Advisor
published General Information

General Information

a developer of antibody-based therapeutic drugs

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
Gottlieb-Daimler-Strabe 2
Phone
+49 621560030
Employees
78
Web
https://www.affimed.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FYBR34.860.11
+0.32%
Frontier Communications Parent
ZTS175.140.51
+0.29%
ZOETIS
CHCO130.24-0.55
-0.42%
City Holding Company
NEXN7.48-0.19
-2.48%
Nexxen International Ltd
HHS6.40-0.65
-9.22%
Harte Hanks

AFMD and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, AFMD has been loosely correlated with BYSI. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if AFMD jumps, then BYSI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AFMD
1D Price
Change %
AFMD100%
-4.66%
BYSI - AFMD
40%
Loosely correlated
-6.14%
NTLA - AFMD
35%
Loosely correlated
-7.61%
ARWR - AFMD
34%
Loosely correlated
-13.26%
SNPX - AFMD
33%
Loosely correlated
-8.05%
XERS - AFMD
33%
Loosely correlated
-4.26%
More